Evidence map›Paper›PMID 36936474›Full record

ArticleFrontiers in immunology2022

Transcriptomics and metabolomics analysis reveal the anti-oxidation and immune boosting effects of mulberry leaves in growing mutton sheep.

Xiaopeng Cui, Yuxin Yang, Minjuan Zhang, Shuang Liu, Hexin Wang, Feng Jiao, Lijun Bao, Ziwei Lin, Xinlan Wei, Wei Qian and 3 more

Open access · goldFull text read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Short-chain fatty acids in the treatment of ulcerative colitis. Systematic review and meta-analysis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Pooled it
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Association of PD-L1 combined positive score with disease control and response kinetics with first-line pembrolizumab-based therapy in metastatic triple-negative breast cancer: results from routine clinical practice in Poland.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Multifaceted regulation of immune cells in radiation-induced pulmonary fibrosis: from mechanistic insights to targeted therapies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Harnessing cuproptosis: a new avenue for targeted cancer therapies.Apoptosis : an international journal on programmed cell death · 2025
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Xiaopeng CuiCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
Yuxin YangCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
Minjuan ZhangCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
Shuang LiuCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
Hexin WangCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
Feng JiaoCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
Lijun BaoCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
Ziwei LinCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
Xinlan WeiCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
Wei QianCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
Xiang ShiCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
Chao SuCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
Yonghua QianCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
Northwest A&F University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Currently, the anti-oxidation of active ingredients in mulberry leaves (MLs) and their forage utilization is receiving increasing attention. Here, we propose that MLs supplementation improves oxidative resistance and immunity. Methods: We conducted a trial including three groups of growing mutton sheep, each receiving fermented mulberry leaves (FMLs) feeding, dried mulberry leaves (DMLs) feeding or normal control feeding without MLs. Results: Transcriptomic and metabolomic analyses revealed that promoting anti-oxidation and enhancing disease resistance of MLs is attributed to improved tryptophan metabolic pathways and reduced peroxidation of polyunsaturated fatty acids (PUFAs). Furthermore, immunity was markedly increased after FMLs treatment by regulating glycolysis and mannose-6-phosphate pathways. Additionally, there was better average daily gain in the MLs treatment groups. Conclusion: These findings provide new insights for understanding the beneficial effects of MLs in animal husbandry and provide a theoretical support for extensive application of MLs in improving nutrition and health care values.

Indexed as

MorusRed MeatAnimalsFatty Acids, UnsaturatedGene Expression ProfilingSheepSheep, DomesticTranscriptomeFatty Acids, Unsaturatedanti-oxidationglycolysisimmunitymulberry leavesperoxidation of polyunsaturated fatty acidstryptophan metabolism

Identifiers

PMID36936474
PMCPMC10015891
OpenAlexW4322734556

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read33
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.